Dimensional variability in molded plastics drives jams and mis-picks at 100–160 PPM, making vision-guided orientation and continuous-motion turret assembly preferable to purely mechanical sorting and ...

PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions for the pharmaceutical, biotechnology ...

The fixed-dose, multi-use pen injector platform features a pull-push mechanism designed to reduce use error while supporting delivery volumes up to 0.75 mL Stevanato ...

Deora™ is Stevanato Group's multi-use, fixed-dose pen injector designed for subcutaneous drug delivery in therapies such as diabetes and weight management. Featuring an intuitive pull‑push mechanism, ...

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions for the pharmaceutical, biotechnology, and life sciences industries, today ...

SAO PAULO, May 26 (Reuters) - Brazil's health regulator Anvisa said on Tuesday it had approved EMS's Ozivy, the country's first semaglutide-based ‌injector pen, as the drugmaker looks to expand into a ...

Trump rambles about Biden’s ‘auto-pen’ to bemused children at Easter egg roll - Coffee found to have startling effect on aging, says new study An asteroid exploded over Russia - and we never saw it ...

Tremfya is a biologic medication administered via injections into a vein or under the skin to treat plaque psoriasis. It works by blocking interleukin-23, a protein involved in the overactive immune ...

Embecta aims to use Owen Mumford's Aidaptus auto-injector to help it transform into a broad-based medical supplies company. (iStock/Getty Images Plus) Diabetes hardware company embecta aims to look ...

Johnson & Johnson said the FDA has approved its once-daily psoriasis pill Icotyde. Icotyde targets IL-23, rivaling best-selling shots Tremfya and Skyrizi. J&J hasn't announced how much Icotyde will ...

Tremfya (guselkumab) has potential interactions with certain other medications, such as abatacept (Orencia) and paroxetine (Brisdelle, Paxil). Using Tremfya may affect how your body responds to ...

Johnson & Johnson JNJ announced that the European Commission (EC) has approved an expanded use of its blockbuster psoriasis drug, Tremfya, in children. Tremfya is now approved to treat pediatric and ...